Disc Medicine, Inc.

IRON Nasdaq SEC CIK 1816736
Follow Disc Medicine Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Net income −$59.5M +4.5% vs same quarter last year
EPS, diluted −$1.53 +13.6% vs same quarter last year
Operating cash flow −$40.2M +15.9% vs same quarter last year
Operating income −$64.2M +5.2% vs same quarter last year
Net income by quarter
−$29.5M
−$34.1M
−$55.2M
−$62.3M
−$60.5M
−$63.5M
−$59.5M
−$59.5M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income7 fiscal years
−$300M−$200M−$100M$0FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearNet income
FY25−$212.2M
FY24−$109.4M
FY23−$76.4M
FY22−$46.8M
FY21−$36M
FY20−$40.8M
FY19-
Free cash flowOperating cash flow minus capital expenditure
−$200M−$150M−$100M−$50M$0FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearFree cash flow
FY25−$181.3M
FY24−$94.4M
FY23−$73.6M
FY22−$42.4M
FY21−$27.6M
FY20−$32.7M
FY19-